Xiaoli Mi

机构：Memorial Sloan Kettering Cancer Center, Kettering University · ORCID：0000-0002-0348-1001

发表论文 41 篇 · 总被引 592 次 · h-index 12

代表论文

• Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127 (2024 · Science · 被引 158)
• CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia (2025 · Blood · 被引 31)
• Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies (2025 · Leukemia · 被引 14)
• CD371-Targeted CAR T-Cells Secreting Interleukin-18 Exhibit Robust Expansion and Disease Clearance in Patients with Refractory Acute Myeloid Leukemia (2024 · Blood · 被引 11)
• Genetic Basis of Relapse after GPRC5D-Targeted CAR T Cells (2023 · Blood · 被引 9)
• Augmenting CAR T-cell Functions with LIGHT (2024 · Cancer Immunology Research · 被引 4)